Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 323
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01842256 | Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin. | ||
| NCT07304700 | Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/10/1000mg in Healthy Volunteers | ||
| NCT02651753 | A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 | ||
| NCT03726853 | The Clinical Trial to Evaluate the Efficacy and Safety of CKD-497 | ||
| NCT06695572 | Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy Volunteers | ||
| NCT04987970 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg | ||
| NCT03770052 | Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie | ||
| NCT00826644 | Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient | ||
| NCT02005744 | A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function | ||
| NCT05843162 | A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome | ||
| NCT03858725 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-374 5 mg in Healthy Volunteers | ||
| NCT04906798 | Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions | ||
| NCT02288338 | CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers | ||
| NCT03246880 | Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients | ||
| NCT01352689 | CKD-828(80/2.5mg) Pharmacokinetic Study_2nd | ||
| NCT06838286 | Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes | ||
| NCT04673695 | A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 | ||
| NCT01684605 | Pharmacokinetics Study of CKD-11101 and NESP After IV Administration in Health Male Volunteers | ||
| NCT07439094 | A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer | ||
| NCT04431687 | A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393) | ||
| NCT03950843 | A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation | ||
| NCT02548286 | Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs | ||
| NCT01030679 | Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus | ||
| NCT02002611 | Drug-drug Interaction Study(Lobeglitazone, Warfarin) | ||
| NCT03063697 | Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure | ||
| NCT02827890 | CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1) | ||
| NCT04334213 | A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D745 and D150 | ||
| NCT01630018 | Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial | ||
| NCT01071720 | The Effect of Food on the Pharmacokinetic Characteristics of CKD-501 | ||
| NCT03017950 | Pharmacokinetic Drug-drug Interaction of CKD-330 and D086 | ||
| NCT01910077 | Bioequivalence Study of Tacrobell Capsule 1mg to Prograf Capsule 1mg | ||
| NCT01243775 | BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLC | ||
| NCT01756430 | Efficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential Hypertension | ||
| NCT04322032 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-389 | ||
| NCT01842230 | Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine | ||
| NCT02156544 | Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 | ||
| NCT04857177 | A Study To Evaluate CKD-701 and Lucentis® in Patients With Neovascular(Wet) Age Related Macular Degeneration | ||
| NCT02047175 | CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin) | ||
| NCT02565368 | A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers | ||
| NCT03868072 | Study to Evaluate the Bioequivalence of Pfizer Korea Inc. "XELJANZ 5Mg Tablet" in Healthy Volunteers | ||
| NCT05540912 | Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy Subjects | ||
| NCT04555434 | Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH | ||
| NCT05698043 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg | ||
| NCT03150316 | CKD-581 + Lenalidomide + Dexamethasone in Patients With Previously Treated Multiple Myeloma | ||
| NCT01340248 | A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers | ||
| NCT04840745 | The Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1 | ||
| NCT03382795 | Retreatment With Epidermal Growth Factor Receptor(EGFR) Tyrosine Kinase Inhibitor in EGFR Mutation Positive Patients | ||
| NCT05526703 | Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy | ||
| NCT02811731 | Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B | ||
| NCT04511000 | Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg |
